This inventor holds 1 USPTO granted patent. Top assignee: Netech Corporation. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Daisuke Wakamatsu: Innovator in Blood Cell Separation Technology
Introduction
Daisuke Wakamatsu is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of biomedical technology, particularly in the area of blood cell separation. His innovative methods have the potential to enhance medical procedures and improve patient outcomes.
Latest Patents
Wakamatsu holds a patent for a method for selectively separating blood cells using lectin. This invention provides a selective and high-yield method for the separation, concentration, and recovery of desired cells from a blood sample. The process involves interacting the blood sample with lectins under specific conditions, leading to the formation of cell-lectin complexes. These complexes are then immobilized on a substrate, allowing for the effective recovery of desired blood cells.
Career Highlights
Daisuke Wakamatsu is associated with Netech Corporation, where he continues to develop and refine his innovative techniques. His work has garnered attention for its practical applications in medical and research settings. Wakamatsu's dedication to advancing technology in the biomedical field is evident through his focused research and development efforts.
Collaborations
Wakamatsu collaborates with esteemed colleagues such as Hirofumi Yura and Yoshio Saito. Their combined expertise contributes to the advancement of technologies that can significantly impact healthcare.
Conclusion
Daisuke Wakamatsu's contributions to blood cell separation technology exemplify the importance of innovation in the medical field. His patented methods have the potential to revolutionize how blood samples are processed, ultimately benefiting patients and healthcare providers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile